IDA honours Dr. P Vijay Anand Reddy for contributions to oncology
Abbott launches minimally invasive TriClip therapy in India
Miror Therapeutics partners with BESCOM to drive menopause awareness among women employees
FUJIFILM Biosciences & NextCell launch platform to standardize regenerative medicine development
WHO rolls out new TB testing toolkit to bring diagnosis closer to patients
Symeres appoints Henning Steinhagen as CEO to drive next phase of global growth
From lab bench to market: Strengthening translational research in India’s biotech ecosystem
Over 3,500 participate in NHA's AI hackathon
Dr. Jitendra Singh calls for stronger research ecosystem
FDA clears Rivanna’s Accuro XV AI-powered 3D ultrasound system
The once-daily oral therapy is the first and only tyrosine kinase 2 (TYK2) inhibitor approved in the European Union for this indication, marking a significant expansion of its immunology portfolio
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes
